Global Carotid Stent Market 2024-2030
  • CHOOSE LICENCE TYPE
Consulting Services
    How will you benefit from our consulting services ?

Global Carotid Stent Market 2024-2030

Last Updated:  Apr 25, 2025 | Study Period: 2024-2030

CAROTID STENT MARKET 

 

INTRODUCTION

Carotid angioplasty and stenting are operations used to open blocked arteries in order to restore blood flow to the brain. They are frequently used to treat or prevent strokes.The carotid arteries run along both sides of the neck.

 

These are the major arteries that carry blood to the brain. They can become blocked with fatty deposits (plaque) that delay or block blood flow to the brain, resulting in carotid artery disease and stroke.

 

The operation entails inserting and inflating a small balloon into the obstructed artery to temporarily expand the region and allow blood to flow freely to the brain.Carotid angioplasty is frequently paired with a treatment known as stenting. Stenting is the process of inserting a tiny metal coil (stent) into a blocked artery.

 

The stent keeps the artery open and reduces the likelihood of it closing again. When standard carotid surgery (carotid endarterectomy) is not possible or is too hazardous, carotid angioplasty and stenting may be utilized. Complications are possible with every medical procedure. Here are some of the risks associated with carotid angioplasty and stenting:

 

Stroke or ministroke (TIA, or transient ischemic attack). Blood clots that develop during angioplasty might break free and go to the brain. To lessen this risk, blood thinners will be given throughout the surgery.A stroke can potentially occur if plaque in the artery becomes dislodged as the catheters are inserted into blood arteries.

 

Restenosis is a new narrowing of the carotid artery. One significant disadvantage of carotid angioplasty is the risk of stroke.chance artery will re-narrow within months following the treatment. To lower the risk of restenosis, special drug-coated stents have been created. Following the operation, medications are provided to reduce the chance of restenosis.

 

Clots form in the blood. Even weeks or months after angioplasty, blood clots can grow within stents. These clots have the potential to cause a stroke or death. To reduce the likelihood of clots developing in stents, take aspirin, clopidogrel (Plavix), and other drugs exactly as directed.

 

Bleeding. may experience bleeding where catheters were put in the groin or wrist. Usually, this results in a bruise, but significant bleeding might occur, necessitating a blood transfusion or surgical operations.The carotid arteries are the blood vessels that supply blood to brain and face. Each side of the cervical spine has a carotid artery.

 

Plaque, a fatty substance, can partially or completely restrict blood flow in this artery. Carotid artery stenosis (narrowing) refers to a partial obstruction. A carotid artery blockage might limit blood flow to the brain. Part of a plaque can sometimes break off and obstruct another artery. A stroke can develop if the brain does not receive adequate blood flow.

 

The carotid arteries are the blood vessels that supply blood to the brain and face. Each side of the cervical spine has a carotid artery.Plaque, a fatty substance, can partially or completely restrict blood flow in this artery. Carotid artery stenosis (narrowing) refers to a partial obstruction.

 

A carotid artery blockage might limit blood flow to the brain. Part of a plaque can sometimes break off and obstruct another artery. A stroke can develop if the brain does not receive adequate blood flow.

 

Carotid endarterectomy (CEA) has traditionally been the principal treatment procedure for high-grade asymptomatic and symptomatic carotid artery stenosis. A carotid endarterectomy includes exposing the carotid artery and removing plaque, most commonly from the middle artery.

 

Carotid endarterectomy (CEA) has traditionally been the principal treatment procedure for high-grade asymptomatic and symptomatic carotid artery stenosis. A carotid endarterectomy includes exposing the carotid artery and removing plaque, most commonly from the middle artery.

 

Carotid endarterectomy (CEA) has traditionally been the principal treatment procedure for high-grade asymptomatic and symptomatic carotid artery stenosis. Through a neck incision, the carotid artery is exposed and plaque is removed, most often from the carotid bulb and the proximal internal carotid artery. However, minimally invasive procedures in vascular surgery, as in many other surgical disciplines, have progressed through time.

 

 These procedures have the advantages of smaller incisions, less postoperative discomfort, a lower risk of postoperative wound problems, and a shorter hospital stay. One such procedure is carotid artery stenting (CAS), which can be done either a transfemoral or a transcarotid route.

 

CAROTID STENT MARKET  SIZE AND FORECAST

 

infographic : Carotid Stent Market , Carotid Stent Market Size, Carotid Stent Market Trend, Carotid Stent Market ForeCast, Carotid Stent Market Risks, Carotid Stent Market Report, Carotid Stent Market Share

 

The Global Carotid Stent Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

 

CAROTID STENT MARKETMARKET DYNAMICS

Boston Scientific Corporation announced that the FDA has authorized its Carotid WALLSTENT(R) Monorail(R) Endoprosthesis for the treatment of patients with carotid artery disease who are at high surgical risk. In Europe and other foreign markets, the Carotid WALLSTENT Endoprosthesis is the main carotid stent. The company stated that it intends to launch the product in the United States immediately.

 

The Carotid WALLSTENT is a self-expanding stent attached on a rapid exchange delivery system that is aimed to reopen the carotid artery and enhance blood flow to the brain by treating stenosis. The stent has a closed-cell architecture that has been created to provide superior lesion coverage and angiographic findings. The technology is intended to be extremely deliverable and to offer access to the most difficult lesions.

 

It is utilized in tandem with the FilterWire EZ(TM) Embolic Protection System, which is designed to trap plaque debris generated during the stenting operation, preventing it from traveling to the brain and increasing the risk of stroke.

 

The device enables quick preparation, deployment, and retrieval as well as simplified filter sizing to accommodate vessel diameters ranging from to.The Carotid WALLSTENT Endoprosthesis with the FilterWire EZ System is the only carotid artery stent system authorized in the United States for the treatment of bilateral carotid artery disease (blockages in both carotid arteries in the neck).

 

The carotid arteries are the primary blood vessels that carry oxygenated blood from the heart to the brain. Carotid artery disease develops when fatty plaque accumulates.

 

This causes the vessels to stiffen and constrict, increasing the risk of stroke. The majority of individuals with carotid artery disease are treated with carotid endarterectomy, a surgical treatment that involves a neck incision and the removal of plaque from the vessel walls. Carotid artery stenting is a less intrusive procedure in which a stent is supplied to the location of the blockage and expanded, pushing the artery walls open and restoring blood flow. 

 

CAROTID STENT MARKETCOMPANY PROFILE

  • Medscape
  • Mount Sinai
  • Frontiers
  • Cleveland Clinic
  • CMS

CAROTID STENT MARKETTHIS REPORT WILL ANSWER FOLLOWING QUESTIONS

  1. How many  Carotid Stents   are manufactured per annum globally? Who are the sub-component suppliers in different regions?
  2. Cost breakup of a Global Carotid Stent   and key vendor selection criteria
  3. Where is the Carotid Stent  manufactured? What is the average margin per unit?
  4. Market share of Global Carotid Stent   market  manufacturers and their upcoming products
  5. Cost advantage for OEMs who manufacture Global Carotid Stent   in-house
  6. 5 key predictions for next 5 years in Global Carotid Stent   market
  7. Average B-2-B  Carotid Stent market price in all segments
  8. Latest trends in  Carotid Stent market, by every market segment
  9. The market size (both volume and value) of the  Carotid Stent   market in 2024-2030 and every year in between?
  10. Production breakup of  Carotid Stent   market, by suppliers and their OEM relationship
1Market Segmentation
2Scope of the report
3Abbreviations
4Research Methodology
5Executive Summary
6Introduction
7Insights from Industry stakeholders
8Cost breakdown of Product by sub-components and average profit margin
9Disruptive innovation in the Industry
10Technology trends in the Industry
11Consumer trends in the industry
12Recent Production Milestones
13Component Manufacturing in US, EU and China
14COVID-19 impact on overall market
15COVID-19 impact on Production of components
16COVID-19 impact on Point of sale
17Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
18Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
19Market Segmentation, Dynamics and Forecast by Application, 2024-2030
20Market Segmentation, Dynamics and Forecast by End use, 2024-2030
21Product installation rate by OEM, 2023
22Incline/Decline in Average B-2-B selling price in past 5 years
23Competition from substitute products
24Gross margin and average profitability of suppliers
25New product development in past 12 months
26M&A in past 12 months
27Growth strategy of leading players
28Market share of vendors, 2023
29Company Profiles
30Unmet needs and opportunity for new suppliers
31Conclusion
32Appendix